Trials / Terminated
TerminatedNCT01673360
Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 401 (actual)
- Sponsor
- ASTORA Women's Health · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To monitor post-market performance through evaluation of short and long-term performance via: * Efficacy * Safety * Patient reported outcomes
Detailed description
As this is a post-market registry on market approved devices, there will be no formal hypothesis testing. However, points of evaluation will include: * Characterize the efficacy of the AMS market approved female pelvic health products using standard of care outcome measures and validated quality of life questionnaires * Characterize the type, severity, and rate of adverse events related to each AMS market approved female pelvic health product * Collect concomitant procedural data related to the pelvic floor area
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Elevate PC | List of AMS prolapse products |
| DEVICE | Mini Arc Pro | List of AMS Urinary Incontinence devices |
| DEVICE | RetroArc | List of AMS Urinary Incontinence devices |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2020-12-01
- Completion
- 2021-12-01
- First posted
- 2012-08-28
- Last updated
- 2016-06-17
Locations
19 sites across 8 countries: United States, Canada, France, Germany, Slovenia, South Africa, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01673360. Inclusion in this directory is not an endorsement.